Literature DB >> 14598250

Reduced migration of fibroblasts in inflammatory bowel disease: role of inflammatory mediators and focal adhesion kinase.

Sandra Nicole Leeb1, Daniela Vogl, Manuela Gunckel, Stephan Kiessling, Werner Falk, Michael Göke, Jürgen Schölmerich, Cornelia Maria Gelbmann, Gerhard Rogler.   

Abstract

BACKGROUND & AIMS: Crohn's disease (CD) and ulcerative colitis (UC) are associated with chronic tissue damage and continuous tissue repair. A central, but not well-characterized, event during this process is the migration of activated fibroblasts to the wound.
METHODS: Human colonic lamina propria fibroblasts (CLPF) were isolated from patients with CD and UC and from healthy controls and were characterized by immunocytochemistry. Migration assays of CLPF were performed in the modified 48-well Boyden chamber. Focal adhesion kinase (FAK) and FAK autophosphorylation in migrating CLPF were determined by Western blotting. FAK mRNA expression was investigated by Northern blotting.
RESULTS: The migration of CD-CLPF and UC-CLPF was significantly reduced when compared with control-CLPF. This was correlated with a decrease in FAK phosphorylation, whereas, in migrating control-CLPF, an increase was found. Similarly, the presence of the inflammatory mediators interferon (IFN)-gamma (50 ng/mL) or tumor necrosis factor (TNF) (30 ng/mL) in conditioned medium significantly reduced the migration of control-CLPF to 41% +/- 4% or 30% +/- 7%, respectively. Preincubation of control-CLPF with TNF (20 ng/mL) and IFN-gamma (10 ng/mL) for 3 days reduced their migratory response to 10% of control (P < 0.001), which also was correlated with a decrease in FAK phosphorylation. Culture of IFN-gamma/TNF-treated CLPF for a further 7 days without cytokines did not restore the migratory potential and FAK phosphorylation, indicating a persistent functional change.
CONCLUSIONS: CD- and UC-CLPF have a reduced migratory potential compared with normal CLPF. That may be caused by contact with IFN-gamma and TNF. This loss of migratory potential was correlated with diminished FAK phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598250     DOI: 10.1016/j.gastro.2003.07.004

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  34 in total

Review 1.  Immunopathogenesis of IBD: current state of the art.

Authors:  Heitor S P de Souza; Claudio Fiocchi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-12-02       Impact factor: 46.802

2.  Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts.

Authors:  Jon Sponheim; Jürgen Pollheimer; Trine Olsen; Johanna Balogh; Clara Hammarström; Tamara Loos; Monika Kasprzycka; Dag Reidar Sørensen; Hogne Røed Nilsen; Axel M Küchler; Morten H Vatn; Guttorm Haraldsen
Journal:  Am J Pathol       Date:  2010-10-29       Impact factor: 4.307

Review 3.  Wound healing and fibrosis in intestinal disease.

Authors:  F Rieder; J Brenmoehl; S Leeb; J Schölmerich; G Rogler
Journal:  Gut       Date:  2007-01       Impact factor: 23.059

4.  Regulation of galectin-3 function in mucosal fibroblasts: potential role in mucosal inflammation.

Authors:  E Lippert; M Gunckel; J Brenmoehl; F Bataille; W Falk; J Scholmerich; F Obermeier; G Rogler
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

5.  Fibrocytes, inflammation, and fibrosis in Crohn's disease: another piece of the puzzle.

Authors:  D Sorrentino
Journal:  Dig Dis Sci       Date:  2014-04       Impact factor: 3.199

Review 6.  Wound repair: role of immune-epithelial interactions.

Authors:  G Leoni; P-A Neumann; R Sumagin; T L Denning; A Nusrat
Journal:  Mucosal Immunol       Date:  2015-07-15       Impact factor: 7.313

Review 7.  Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease.

Authors:  Florian Rieder; Sean Kessler; Miquel Sans; Claudio Fiocchi
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-08-09       Impact factor: 4.052

8.  Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.

Authors:  Florian Rieder; Sean P Kessler; Gail A West; Shardul Bhilocha; Carol de la Motte; Tammy M Sadler; Banu Gopalan; Eleni Stylianou; Claudio Fiocchi
Journal:  Am J Pathol       Date:  2011-09-21       Impact factor: 4.307

Review 9.  Immunological roles of intestinal mesenchymal cells.

Authors:  Robert J Nibbs; Kathy D McCoy; Allan Mcl Mowat; Carolyn A Thomson
Journal:  Immunology       Date:  2020-04-20       Impact factor: 7.397

10.  Resveratrol inhibits collagen I synthesis by suppressing IGF-1R activation in intestinal fibroblasts.

Authors:  Ping Li; Mei-Lan Liang; Ying Zhu; Yao-Yao Gong; Yun Wang; Ding Heng; Lin Lin
Journal:  World J Gastroenterol       Date:  2014-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.